Sponsors (12)
The bill directs new, time-limited federal funding and grants to accelerate research, trials, and implementation of TBI/mTBI treatments for veterans and to improve evidence and administrative clarity — but it requires taxpayer funding, may divert existing VA mental-health resources, imposes implementation limits (grant caps and short duration), and could leave some veterans or services excluded unless Congress provides sustained, larger-scale support.
Veterans with chronic mTBI/TBI gain access to new evidence-based neurorehabilitation and TBI treatments through funded clinical trials, pilot programs, and implementation efforts.
This bill provides new federal funding to support TBI/mTBI research and innovation (including the $30M authorization over FY2026–FY2028 and additional annual authorizations), sustaining pilot studies and program activity during the grant period.
Researchers, nonprofit providers, and academic partners receive dedicated grant funding (including reserved exploratory grants for nonprofits) to develop and test TBI therapies, strengthening the evidence base and community-provider role in veteran care.
Veterans and providers may face discontinuity because the program is time-limited to three years, risking loss of services and stalled scaling of promising interventions if Congress does not renew or extend funding.
Taxpayers face increased federal spending (authorized amounts including $30M and additional annual authorizations), which may require budget tradeoffs elsewhere in VA or the federal budget if not offset.
Grant caps and a relatively small number/size of awards (e.g., per-grantee limits and a limited annual grant set) could limit geographic reach, scale-up, and leave many promising projects or veteran populations unfunded.
Based on analysis of 4 sections of legislative text.
Introduced January 9, 2026 by John Bergman · Last progress January 9, 2026
Creates two short-term Department of Veterans Affairs grant programs to fund research, clinical trials, training, and outreach focused on traumatic brain injury (TBI), with an emphasis on chronic mild TBI (mTBI) in veterans. One program (Innovation Grant Program) awards competitively to nonprofits, academic institutions, non-VA clinical providers, and other approved entities (grants up to $5M per grantee/year) and is authorized $30M for FY2026–FY2028; the other establishes a VA research grant program run through an independent third party to fund exploratory and collaborative clinical research (specific grant caps) and is authorized $10M per year for FY2026–FY2028. Both programs require applications, annual reporting, oversight, and timelines tied to enactment (regulations within 180 days; program authorities terminate three years after enactment).